Medical Devices - Japan | Statista Market Forecast

The projected revenue in the Medical Devices market market in Japan is estimated to reach US$28.97bn in 2024.
Within this market, the largest market is Cardiology_Devices, which is projected to have a market volume of US$5.11bn in the same year.
Looking ahead, the revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 5.56%, leading to a market volume of US$37.97bn by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$181.00bn in 2024.
Japan's medical device market is experiencing a surge in demand for advanced imaging technology, driving innovation and competition among industry players.

Definition:
The Medical Devices market includes instruments and machines helping for the prevention, diagnosis, and treatment of diseases. This market is further broken down into 6 submarkets according to medical specialties or types of application. Medical devices that treat the heart, such as pacemakers, can be found in the Cardiology Devices market. The Diagnostic Imaging market covers machines and instruments for diagnosis of many different kinds of conditions. Devices for orthopedic applications, such as joint implants, are included in the Orthopedic Devices market. Ophthalmic Devices are devices used for conditions related to the eye. The General & Plastic Surgery Devices covers many different products required for surgeries. The Other Medical Devices market provides information on additional areas that are not covered by the main markets.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Siemens Healthineers.

Implants and prostheses
Assistive technology products (e.g., hearing aids, wheelchairs)
Clinical engineering products
Imaging devices
Active medical devices (i.e., operating with electrical energy)

Services (i.e., treatment expenses)
Consumer technologies, e.g., fitness trackers
Products for laboratory testing (IVD)

The Medical Devices market in Japan has been experiencing steady growth over the past few years.

Customer preferences: Japanese consumers have a strong preference for technologically advanced and innovative medical devices. They value products that are reliable, efficient, and easy to use. Additionally, there is a growing demand for devices that can improve the quality of life for the aging population in Japan. As the country has one of the highest life expectancies in the world, there is a need for medical devices that can address age-related health issues such as mobility, chronic diseases, and cognitive decline.

Trends in the market: One of the key trends in the Medical Devices market in Japan is the increasing adoption of digital health technologies. This includes wearable devices, remote monitoring systems, and telemedicine solutions. These technologies allow for better management of chronic conditions, remote patient monitoring, and improved access to healthcare services. The COVID-19 pandemic has further accelerated the adoption of digital health technologies, as it has highlighted the need for remote healthcare solutions and telemedicine consultations. Another trend in the market is the focus on personalized medicine. There is a growing interest in medical devices that can provide personalized treatment options based on an individual's genetic makeup and specific health conditions. This includes devices such as genetic testing kits, personalized drug delivery systems, and implantable devices that can monitor and adjust treatment based on real-time data.

Local special circumstances: Japan has a rapidly aging population, with a declining birth rate. This demographic shift has significant implications for the Medical Devices market. There is a growing demand for devices that can improve the quality of life for the elderly population, such as mobility aids, home healthcare devices, and assistive technologies. Additionally, there is a need for devices that can address age-related health issues, such as cardiovascular diseases, diabetes, and dementia.

Underlying macroeconomic factors: Japan has a well-developed healthcare system and a strong focus on research and development. The government has been actively promoting innovation in the healthcare sector and has implemented policies to support the development and adoption of medical devices. This includes providing funding for research and development, streamlining regulatory processes, and promoting collaboration between industry and academia. Furthermore, Japan has a high level of healthcare expenditure, driven by the aging population and the prevalence of chronic diseases. This provides a favorable market environment for medical device manufacturers and suppliers. The government is also actively promoting medical tourism, which further contributes to the growth of the Medical Devices market. In conclusion, the Medical Devices market in Japan is driven by customer preferences for technologically advanced and innovative devices, the increasing adoption of digital health technologies, and the focus on personalized medicine. The local special circumstances, such as the aging population and the need for devices that address age-related health issues, further contribute to market growth. The underlying macroeconomic factors, including a well-developed healthcare system, government support for innovation, and high healthcare expenditure, provide a favorable market environment for medical device manufacturers and suppliers.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.